SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-16-000558
Filing Date
2016-02-09
Accepted
2016-02-09 14:25:58
Documents
1
Group Members
CLARUS VENTURES I LLCCLARUS VENTURES I MANAGEMENT L.P.DENNIS HENNERKURT WHEELERMICHAEL STEINMETZNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 VBI VACCINES INC. - AMEND. #1 clarus-vbi13d_17901.htm SC 13D/A 276027
  Complete submission text file 0001072613-16-000558.txt   278038
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Subject) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-41542 | Film No.: 161398797
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences I, L.P. (Filed by) CIK: 0001431445 (see all company filings)

IRS No.: 203855540 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A